Talquetamab Offers New Hope in Relapsed/Refractory Multiple Myeloma

(MedPage Today) -- NEW ORLEANS--Talquetamab had substantial antitumor effects in patients with heavily pretreated relapsed or refractory multiple myeloma, a researcher reported here.
In a 288-patient, phase I/II study that assessed the agent...